寶鷹股份(002047.SZ):上半年預虧2億元–2.4億元
格隆匯7月9日丨寶鷹股份(002047.SZ)公佈2024年半年度業績預吿,報吿期歸屬於上市公司股東的淨利潤虧損2億元–2.4億元,上年同期虧損21,951.79萬元;扣除非經常性損益後的淨利潤虧損1.98億元-2.38億元,上年同期虧損22,012.57萬元;基本每股收益虧損0.13元/股–0.16元/股。
2024年1-6月歸屬於上市公司股東的淨利潤虧損主要原因是營業收入下降、計提的減值準備等綜合因素影響所致。報吿期內,受市場競爭激烈、行業增速較低等因素影響,導致營業收入同比下滑;同時基於謹慎性原則,報吿期內根據應收賬款回款情況計提相應減值準備。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.